Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma

Pathology and Oncology Research

Volumn 13, Issue 2, 2007, Pages 105-113

  Sanada, Yuichi ^a   Yoshida, Kazuhiro ^a   Ohara, Masahiro ^a   Tsutani, Yasuhiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Gallbladder carcinoma; Hepatocellular carcinoma; OPRT; Pancreatic carcinoma; Pancreatic intraepithelial neoplasia (PanIN)

Indexed keywords

OROTATE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MALE; PANCREAS CARCINOMA; PROTEIN EXPRESSION;

EID: 34547626229     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893485     Document Type: Article

References (22)

1. Sakamoto K, Sugimoto Y, Miyadera K, et al: Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunohistochemical detection in human tumor cells. Int J Mol Med 16: 245-249, 2005
2. Oguri T, Achiwa H, Bessho Y, et al: The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. Lung Cancer 49: 345-351, 2005
3. Ishida H, Shirakawa K, Ohsawa T, et al Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer-relationships among mRNA expression with response to 5-FU based treatment. Gan To Kagaku Ryoho 32: 1929-1934. 2005 (in Japanese)
4. Kamoshida S, Shiogama K, Shimomura R, et al: Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer. Oncol Rep 14: 1223-1230, 2005
5. Ochiai T, Sugitani M, Nishimura K, et al: Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer. Oncol Rep 14: 987-992, 2005
6. Nakano J, Huang C, Liu D, et al: Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT. Br J Cancer 95: 607-615, 2006
7. Ochiai T, Nishimura K, Noguchi H, et al: Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy. J Surg Oncol 94: 45-50, 2006
8. Takaori K, Kobayashi Y, Matsusue S, et al: Pancreatic intraepithelial neoplasia. Pancreas 28: 257-261, 2004
9. Lemoine NR, Jain S, Hughes CM, et al: K-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102: 230-236, 1992
10. Wilentz RE, Lacobuzio-Donahue CA, Argani P, et al: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that Dpc4 inactivation occurs late in neoplastic progression. Cancer Res 60: 2002-2006, 2000
11. Kim GE, Bae HI, Park HU, et al: Aberrant expression of MUC5AC and MUC6 gastric mucin and Sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123: 1052-1060, 2002
12. Sanada Y, Yoshida K, Ohara M, et al: Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 32: 164-170, 2006
13. Albores-Saavedra J, Shukla D, Carrick K, Henson DE: In situ and invasive adenocarcinomas of gallbladder extending into or arising from Rokitansky-Aschoff sinuses. A clinicopathologic study of 49 cases. Am J Surg Pathol 28: 621-628, 2004
14. Kojiro M: Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 19: 39-62, 2005
15. Mizutani Y, Wada H, Fukushima M, et al: Prognostic significance of orotate phosphoribosyl transferase activity in bladder carcinoma. Cancer 100: 723-731, 2004
16. Takamori H, Kanemitsu K, Tsuji T, et al: 5-fluorouracil intraarterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer. Pancreas 30: 223-226, 2005
17. Alberts SR, al-Khatib H, Mahoney MR, et al: Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gall-bladder carcinoma in North Central Cancer Treatment Group phase II trial. Cancer 103: 111-118, 2005
18. Obi S, Yoshida H, Toure R, et al: Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106: 1990-1997, 2006
19. Sakurai Y, Sakamoto K, Sugimoto Y, et al: Orotate phosphoribosyltransferase levels measured by a newly established enzyme-linked immunosorbent assay in gastric carcinoma. Cancer Sci 97: 492-498, 2006
20. Dhawan P, Singh AB, Deane NG, et al: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776, 2005
21. Doucas H, Garcea G, Neal CP, et al: Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention. Pancreatology 6: 429-439, 2006
22. Hidaka S, Yasutake T, Fukushima M, et al: Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells. Eur J Cancer 39: 975-980, 2003